Tissue Repair Ltd (TRP.AX)

0.2250 +0.0150 (+7.14%) 收市：10:57AM AEST

Tissue Repair Ltd

255 Pitt Street
Level 10
Sydney, NSW 2000
Australia
61 427 985 805
https://www.tissuerepair.com.au

版塊: Healthcare
行業: Biotechnology
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Tony Charara	Co-Founder & Executive Director	100k	無	無
Mr. Cameron Jones C.A.	Chief Financial Officer	無	無	無
Dr. Darryl Reed	Chief Operating Officer	無	無	無
Ms. Sushma Kejriwal	Company Secretary	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 AUD。

描述

Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.

公司管治

截至 無 止，Tissue Repair Ltd 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。